Zentrum fur gynakologische Endokrinologie und Reproduktionsmedizin

Saarbrücken, Germany

Zentrum fur gynakologische Endokrinologie und Reproduktionsmedizin

Saarbrücken, Germany
SEARCH FILTERS
Time filter
Source Type

Deutsch M.,Bar - Ilan University | Afrimzon E.,Bar - Ilan University | Namer Y.,Bar - Ilan University | Shafran Y.,Bar - Ilan University | And 10 more authors.
BMC Cell Biology | Year: 2010

Background: Cryopreservation is the only widely applicable method of storing vital cells for nearly unlimited periods of time. Successful cryopreservation is essential for reproductive medicine, stem cell research, cord blood storage and related biomedical areas. The methods currently used to retrieve a specific cell or a group of individual cells with specific biological properties after cryopreservation are quite complicated and inefficient.Results: The present study suggests a new approach in cryopreservation, utilizing the Individual Cell-based Cryo-Chip (i3C). The i3C is made of materials having appropriate durability for cryopreservation conditions. The core of this approach is an array of picowells, each picowell designed to maintain an individual cell during the severe conditions of the freezing - thawing cycle and accompanying treatments. More than 97% of cells were found to retain their position in the picowells throughout the entire freezing - thawing cycle and medium exchange. Thus the comparison between pre-freezing and post-thawing data can be achieved at an individual cell resolution. The intactness of cells undergoing slow freezing and thawing, while residing in the i3C, was found to be similar to that obtained with micro-vials. However, in a fast freezing protocol, the i3C was found to be far superior.Conclusions: The results of the present study offer new opportunities for cryopreservation. Using the present methodology, the cryopreservation of individual identifiable cells, and their observation and retrieval, at an individual cell resolution become possible for the first time. This approach facilitates the correlation between cell characteristics before and after the freezing - thawing cycle. Thus, it is expected to significantly enhance current cryopreservation procedures for successful regenerative and reproductive medicine. © 2010 Deutsch et al; licensee BioMed Central Ltd.


Afrimzon E.,Bar - Ilan University | Zurgil N.,Bar - Ilan University | Shafran Y.,Bar - Ilan University | Ehrhart F.,Fraunhofer Institute for Biomedical Engineering | And 11 more authors.
BMC Cell Biology | Year: 2010

Background: The cryopreservation and thawing processes are known to induce many deleterious effects in cells and might be detrimental to several cell types. There is an inherent variability in cellular responses among cell types and within individual cells of a given population with regard to their ability to endure the freezing and thawing process. The aim of this study was to evaluate the fate of cryopreserved cells within an optical cryo apparatus, the individual-cell-based cryo-chip (i3C), by monitoring several basic cellular functional activities at the resolution of individual cells.Results: In the present study, U937 cells underwent the freezing and thawing cycle in the i3C device. Then a panel of vital tests was performed, including the number of dead cells (PI staining), apoptotic rate (Annexin V staining), mitochondrial membrane potential (TMRM staining), cytoplasm membrane integrity and intracellular metabolism (FDA staining), as well as post-thawing cell proliferation assays. Cells that underwent the freezing - thawing cycle in i3C devices exhibited the same functional activity as control cells. Moreover, the combination of the multi-parametric analysis at a single cell resolution and the optical and biological features of the device enable an accurate determination of the functional status of individual cells and subsequent retrieval and utilization of the most valuable cells.Conclusions: The means and methodologies described here enable the freezing and thawing of spatially identifiable cells, as well as the efficient detection of viable, specific, highly biologically active cells for future applications. © 2010 Afrimzon et al; licensee BioMed Central Ltd.

Loading Zentrum fur gynakologische Endokrinologie und Reproduktionsmedizin collaborators
Loading Zentrum fur gynakologische Endokrinologie und Reproduktionsmedizin collaborators